China Synthetic Biology Market Size & Outlook, 2026-2033
The synthetic biology market in China is expected to reach a projected revenue of US$ 7,760.6 million by 2033. A compound annual growth rate of 23.9% is expected of China synthetic biology market from 2026 to 2033.
Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc
Other key industry trends
In terms of revenue, China accounted for 7.5% of the global synthetic biology market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China synthetic biology market is projected to lead the regional market in terms of revenue in 2033.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 7,760.6 million by 2033.
Scientific R&D is the fastest-growing sector in China, especially in the area of applied sciences, such as nanotechnology, sustainable energy, and stem cells. Early biotechnology developments in the country focus more on agricultural applications and less on medical and pharmaceutical industries.
However, after the introduction of funding projects—National High-tech R&D Program (863 Program) and National Basic Research Program of China (973 program)—development and use of molecular techniques in biotechnology are expected to become common.
The 973 program is basic research funding. Moreover, the 863 program is high technology development plan used by National Institutes of Health and the Department of Defense. The following table mentions some of the important R&D funding initiatives for biotech in China.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Synthetic Biology Market Outlook will help companies and investors design strategic landscapes.
Pcr Technology was the largest segment with a revenue share of 36.69% in 2025.
Horizon Databook has segmented the China synthetic biology market based on pcr technology, genome editing technology, ngs technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2021 to 2033.
Scientific R&D is the fastest-growing sector in China, especially in the area of applied sciences, such as nanotechnology, sustainable energy, and stem cells. Early biotechnology developments in the country focus more on agricultural applications and less on medical and pharmaceutical industries.
However, after the introduction of funding projects—National High-tech R&D Program (863 Program) and National Basic Research Program of China (973 program)—development and use of molecular techniques in biotechnology are expected to become common.
The 973 program is basic research funding. Moreover, the 863 program is high technology development plan used by National Institutes of Health and the Department of Defense. The following table mentions some of the important R&D funding initiatives for biotech in China.
China Synthetic Biology Market Technology Outlook (Revenue, USD Million , 2021-2033)
PCR Technology
Genome Editing Technology
NGS Technology
Bioprocessing Technology
Other Technologies
China Synthetic Biology Market Product Outlook (Revenue, USD Million , 2021-2033)
Enzymes
Oligonucleotide/Oligo Pools and Synthetic DNA
Cloning Technologies Kits
Xeno-Nucleic Acids
Chassis Organism
China Synthetic Biology Market Application Outlook (Revenue, USD Million , 2021-2033)
Healthcare
Non-healthcare
China Synthetic Biology Market End Use Outlook (Revenue, USD Million , 2021-2033)
Biotechnology and Pharmaceutical companies
Academic and Government Research Institutes
Others
Reasons to subscribe to Synthetic Biology Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Synthetic Biology Market Outlook databook
Our clientele includes a mix of Synthetic Biology Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Synthetic Biology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Synthetic Biology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.